Literature DB >> 6497196

Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome.

J J Lokich, C Moore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6497196     DOI: 10.7326/0003-4819-101-6-798

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  31 in total

Review 1.  Adverse effects of cancer chemotherapy. An overview of techniques for avoidance/minimisation.

Authors:  M Nicolson; R C Leonard
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion.

Authors:  C J Fabian; R Molina; M Slavik; S Dahlberg; S Giri; R Stephens
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

Review 3.  Continuous infusion of chemotherapy: focus on 5-fluorouracil and fluorodeoxyuridine.

Authors:  R L Poorter; P J Bakker; C H Veenhof
Journal:  Pharm World Sci       Date:  1998-04

4.  [Acral necrosis in metastatic ovarian carcinoma. A single episode of Moschowitz syndrome during gemcitabine chemotherapy].

Authors:  M J Behne; U Hauswirth; A Menz; N Brüllke; U Müllerleile; I Moll
Journal:  Hautarzt       Date:  2008-11       Impact factor: 0.751

Review 5.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

6.  Cutaneous toxicity of oral low-dose methotrexate.

Authors:  Priyanka Jalandhara; Gurjit Kaeley
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-22

7.  An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity?

Authors:  Biju Vasudevan
Journal:  Indian J Pharmacol       Date:  2010-10       Impact factor: 1.200

8.  Pegylated liposomal doxorubicin in ovarian cancer.

Authors:  Robert Strother; Daniela Matei
Journal:  Ther Clin Risk Manag       Date:  2009-08-20       Impact factor: 2.423

9.  Hand-foot syndrome due to capecitabine.

Authors:  Amar Surjushe; Resham Vasani; Sudhir Medhekar; Minal Thakre; D G Saple
Journal:  Indian J Dermatol       Date:  2008-01       Impact factor: 1.494

10.  Hand-foot syndrome due to capecitabine.

Authors:  Amar Surjushe; Resham Vasani; Sudhir Medhekar; Minal Thakre; D G Saple
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.